L-Dopa (Levodopa) is an oral medication used to treat Parkinson's disease, the symptoms of which result from a lack of dopamine in the brain. L-Dopa relies on L-type, or leucine-preferring, transport proteins to cross the blood-brain barrier, and it is converted to dopamine in the brain by the enzyme aromatic-L-amino-acid decarboxylase.Properties of L-Dopa:- **Density**: 1.47 g/cm³- **Melting Point**: 278 °C- **Boiling Point**: Decomposes- **Solubility in Water**: Low solubility- **Solubility in Lipids**: Low solubility- **Optical Activity**: Rotates plane-polarized light counterclockwiseClassify each property based on whether it is or is not a property of L-Dopa's enantiomer, D-Dopa. **Properties of D-Dopa**- **Rotates plane-polarized light clockwise:** This refers to D-Dopa's ability to change the direction of plane-polarized light, a common characteristic in stereochemistry used to identify specific configurations. - **Highly soluble in water:** D-Dopa dissolves well in water, indicating its hydrophilic nature.- **Density slightly less than that of L-Dopa:** This suggests that D-Dopa and L-Dopa have different packing arrangements or molecular interactions.- **Solid at room temperature:** D-Dopa exists in solid form under standard room temperature conditions.**Not a Property of D-Dopa**- **Reduces symptoms of Parkinson's disease:** Unlike L-Dopa, which is used as a treatment for Parkinson’s disease, D-Dopa does not have this therapeutic effect.- **Aromatic-L-amino-acid decarboxylase has a different affinity for D-Dopa:** This enzyme interacts differently with D-Dopa compared to L-Dopa, affecting how it is metabolized.- **Good substrate for aromatic-L-amino-acid decarboxylase:** D-Dopa is not efficiently processed by this enzyme, unlike L-Dopa, which is a better substrate.

Levodopa or L-dopa and Dextro- dopa or D-Dopa are enantiomers. Enantiomers are compounds that have a…

L-Dopa (Levodopa) is an oral medication used to treat Parkinson's disease, the symptoms of which result from a lack of dopamine in the brain. L-Dopa relies on L-type, or leucine-preferring, transport proteins to cross the blood-brain barrier, and it is converted to dopamine in the brain by the enzyme aromatic-L-amino-acid decarboxylase. Properties of L-Dopa: • density: 1.47 g/cm melting point: 278 °C • boiling point: decomposes solubility in water: low solubility • solubility in lipids: low solubility • rotates plane-polarized light counterclockwise Classify each property based on whether it is or is not a property of

L-Dopa (Levodopa) is an oral medication used to treat Parkinson's disease, the symptoms of which result from a lack of dopamine in the brain. L-Dopa relies on L-type, or leucine-preferring, transport proteins to cross the blood-brain barrier, and it is converted to dopamine in the brain by the enzyme aromatic-L-amino-acid decarboxylase. Properties of L-Dopa: • density: 1.47 g/cm melting point: 278 °C • boiling point: decomposes solubility in water: low solubility • solubility in lipids: low solubility • rotates plane-polarized light counterclockwise Classify each property based on whether it is or is not a property of

Human Anatomy & Physiology (11th Edition)

11th Edition

ISBN:9780134580999

Author:Elaine N. Marieb, Katja N. Hoehn

Publisher:Elaine N. Marieb, Katja N. Hoehn

Chapter1: The Human Body: An Orientation

Section: Chapter Questions

Problem 1RQ: The correct sequence of levels forming the structural hierarchy is A. (a) organ, organ system,...

See similar textbooks

Similar questions

What would be the most direct result if NAG (N-acetylglucosamine acid) could not be synthesized?
Briefly explain the Warburg Effect. How can the Warburg effect be taken advantage of (HINT: make sure to give DETAILS on the pathway, and molecules / mechanism involved)?
Batrachotoxin identify the species which releases the toxin (if it is man-made then this will be all that is required for this part) identify the step disrupted in the neuromuscular junction pathway Provide any consequences of this disruption. Does the toxin have any applications in biomedicine as a painkiller, disease treatment or analgesic? Please provide sources in APA format
Write a balanced equation for the synthesis of phosphatidylethanolamine by the de novo pathway, starting from ethanolamine, glycerol, and fatty acids.
Define the following terms: a. arginosuccinate b. Krebs bicycle c. N-acetylglutamate d. BH4 e. taurine
This question relates to morphine (shown below) and the relationships betweenchanging chemical structure and biological activity. Intermolecular interactions play a key role in the binding of morphine to its receptor. Statethe types of interaction that may occur and discuss the key structural features of morphineassociated with these interactions.(b) With respect to the parent compound, explain in detail how modifying the rings shownas A, B, C, D and E in morphine can affect the biological activity associated with themolecule.